Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming

TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用

基本信息

  • 批准号:
    10662347
  • 负责人:
  • 金额:
    $ 37.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-25 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

SUMMARY Direct cardiac reprogramming to generated induced cardiomyocytes (iCMs) from fibroblasts has emerged as a promising therapeutic strategy for the treatment of heart failure, which is still the leading cause of mortality and morbidity in the developed country. While much is known regarding iCMs generated from mouse cells, the adaptation of direct cardiac reprogramming to human cells is hurdled with low efficiency and poor quality because of intrinsic differences between species. We recently reported the single cell transcriptomic analysis during human cardiac reprogramming and discovered that the insufficient generation of iCMs is associated with underdeveloped gene programs, such as ion channel and cell junction, suggesting that additional reprogramming factors regulating function of cardiomyocytes might be required. In this research program, we hypothesis that a novel reprogramming factor TBX20 plays an essential role to generate cardiomyocyte identity by establishing gene programs associated with cardiomyocyte function. In support of our hypothesis, our preliminary data have shown that TBX20 is largely under-expressed in human iCMs. While forced expression of TBX20 significantly enhanced reprogramming efficiency accompanied with activation of gene programs associated with cardiomyocyte function. To test the hypothesis, we propose to 1) further determine the impact of TBX20 on direct human cardiac reprogramming and 2) determine how TBX20 functions as an essential reprogramming factor during this process. The main objective of this proposal is to identify the critical role of TBX20 on regeneration of cardiomyocytes during direct cardiac reprogramming. The completion of this proposal will not only provide mechanistic insight into how cardiomyocyte identity can be regenerated by direct cardiac reprogramming but also enable us to generate functional-reliable cardiomyocytes directly from human non-myocytes for potential heart repair.
概括 直接对成纤维细胞产生的诱导心肌细胞(ICM)的心脏重编程已成为一种 有希望治疗心力衰竭的治疗策略,这仍然是死亡率和 发达国家的发病率。虽然对从小鼠细胞产生的ICMS有很多了解,但 直接心脏重编程对人类细胞的适应性低效率和质量差。 由于物种之间的内在差异。我们最近报道了单细胞转录组分析 在人类心脏重新编程期间,发现ICM的产生不足 与离子通道和细胞连接等欠发达的基因程序有关,这表明了其他 可能需要调节心肌细胞功能的重编程因子。在这个研究计划中,我们 假设新型重编程因子TBX20起产生心肌细胞身份的重要作用 通过建立与心肌细胞功能相关的基因程序。为了支持我们的假设 初步数据表明,在人类ICM中,TBX20在很大程度上表现不足。而强迫表达 TBX20的重新编程效率显着提高,并伴随着基因程序的激活 与心肌细胞功能相关。为了检验假设,我们提议1)进一步确定影响 在直接人类心脏重编程中的TBX20和2)确定TBX20的作用是必不可少的 在此过程中重新编程因子。该提案的主要目的是确定 TBX20在直接心脏重编程过程中心肌细胞再生。完成此完成 提案不仅将提供有关如何通过直接再生心肌细胞身份的机械洞察 心脏重新编程,但也使我们能够直接从人身上产生可靠的功能可靠的心肌细胞 非肌细胞潜在的心脏修复。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cardiomyocyte Cell-Cycle Regulation in Neonatal Large Mammals: Single Nucleus RNA-Sequencing Data Analysis via an Artificial-Intelligence-Based Pipeline.
A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming.
  • DOI:
    10.1016/j.xpro.2022.101560
  • 发表时间:
    2022-09-16
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lyra-Leite, Davi M.;Gutierrez-Gutierrez, Oscar;Wang, Meimei;Zhou, Yang;Cyganek, Lukas;Burridge, Paul W.
  • 通讯作者:
    Burridge, Paul W.
共 2 条
  • 1
前往

Yang Zhou的其他基金

Targeting CHI3L and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
  • 批准号:
    10850273
    10850273
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
  • 批准号:
    10554375
    10554375
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
  • 批准号:
    10355479
    10355479
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
  • 批准号:
    9887633
    9887633
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
  • 批准号:
    10033650
    10033650
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
  • 批准号:
    10455734
    10455734
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
  • 批准号:
    10245150
    10245150
  • 财政年份:
    2020
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
  • 批准号:
    10437834
    10437834
  • 财政年份:
    2013
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
  • 批准号:
    10200080
    10200080
  • 财政年份:
    2013
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
  • 批准号:
    9573405
    9573405
  • 财政年份:
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:

相似国自然基金

结合态抗生素在水产品加工过程中的消解机制与产物毒性解析
  • 批准号:
    32302247
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ABHD6与AMPA受体结合位点的鉴定及该位点在AMPA受体转运和功能调控中的作用研究
  • 批准号:
    32300794
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
α-突触核蛋白与脂肪酸结合蛋白FABP3相互作用维持自身低聚体形态的机制研究
  • 批准号:
    82301632
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于荧光共振能量转移机理构建多肽荧光探针用于可视化Zn2+结合SQSTM1/p62调节自噬在前列腺癌去势耐受中的作用机制
  • 批准号:
    82303568
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
手性氢键供体与阴离子结合催化乙烯基醚的立体选择性阳离子聚合
  • 批准号:
    22301279
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
  • 批准号:
    10752555
    10752555
  • 财政年份:
    2024
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
  • 批准号:
    10606132
    10606132
  • 财政年份:
    2024
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
  • 批准号:
    10748776
    10748776
  • 财政年份:
    2024
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别:
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
  • 批准号:
    10537391
    10537391
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
    $ 37.13万
  • 项目类别: